The 19th Annual Food Allergy Ball

December 5, 2016 @ 7:00 pm - 10:00 pm

Event Navigation

The 19th Annual Food Allergy Ball, benefiting Food Allergy Research & Education (FARE), will take place on Monday, December 5, 2016 at The Waldorf Astoria. All proceeds will benefit FARE, the nation’s leading advocacy organization working on behalf of the 15 million Americans with food allergies and the world’s largest private funder of food allergy research.

For their longstanding and commitment to FARE’s mission, the evening will honor Helen and David Jaffe, who raised four adult children with life-threatening food allergies and have a long history of corporate citizenship and personal philanthropy.

Chef Gabriel Kreuther will receive the Lifetime Achievement Award, presented to an outstanding chef for his commitment to excellence and compassion for diners with food allergies. JetBlue Airways is the Corporate Dinner Honoree for the ball.

The festivities for this black-tie Gala start at 7:00 p.m. Ticket prices are as follows: tables are available for $100,000, $50,000, $25,000 and $15,000, and individual tickets are available for $5,000, $2,500 and $1,000. Tony and Grammy award-winner Billy Porter will give a special performance.

About FARE
Food Allergy Research & Education (FARE) works on behalf of the 15 million Americans with food allergies, including all those at risk for life-threatening anaphylaxis. This potentially deadly disease affects 1 in every 13 children in the U.S. – or roughly two in every classroom. FARE’s mission is to improve the quality of life and the health of individuals with food allergies, and to provide them hope through the promise of new treatments. Our work is organized around three core tenets: LIFE – support the ability of individuals with food allergies to live safe, productive lives with the respect of others through our education and advocacy initiatives; HEALTH – enhance the healthcare access of individuals with food allergies to state-of-the-art diagnosis and treatment; and HOPE – encourage and fund research in both industry and academia that promises new therapies to improve the allergic condition.